9216

antibody from Cell Signaling Technology, Inc

Targeting: MAPK13 p38delta, PRKM13, SAPK4

Western blot (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

9216

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#9216, RRID:AB_331296

Product name

Phospho-p38 MAPK (Thr180/Tyr182) (28B10) Mouse mAb

Antibody type

Monoclonal

Reactivity

Human, Mouse, Rat, Simian, Yeast

Host

Mouse

Storage

-20°C

References

Submitted references

RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation.

Li Y, Liu S, Zhang Z, Xu Q, Xie F, Wang J, Ping S, Li C, Wang Z, Zhang M, Huang J, Chen D, Hu L, Li C
PloS one 2012;7(4):e35016

---

Polycomb group protein displacement and gene activation through MSK-dependent H3K27me3S28 phosphorylation.

Gehani SS, Agrawal-Singh S, Dietrich N, Christophersen NS, Helin K, Hansen K
Molecular cell 2010 Sep 24;39(6):886-900

---

Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation.

Xu P, Derynck R
Molecular cell 2010 Feb 26;37(4):551-66

---

Acetaminophen prevents aging-associated hyperglycemia in aged rats: effect of aging-associated hyperactivation of p38-MAPK and ERK1/2.

Wu M, Desai DH, Kakarla SK, Katta A, Paturi S, Gutta AK, Rice KM, Walker EM Jr, Blough ER
Diabetes/metabolism research and reviews 2009 Mar;25(3):279-86

---

NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages.

Basak C, Pathak SK, Bhattacharyya A, Mandal D, Pathak S, Kundu M
The Journal of biological chemistry 2005 Feb 11;280(6):4279-88